Home/Filings/4/0000899243-22-009378
4//SEC Filing

Rao Srinivas 4

Accession 0000899243-22-009378

CIK 0001840904other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 3:56 PM ET

Size

10.3 KB

Accession

0000899243-22-009378

Insider Transaction Report

Form 4
Period: 2022-03-02
Rao Srinivas
See Remarks
Transactions
  • Award

    Stock Option

    2022-03-02+1,307,4081,307,408 total
    Exercise: $2.44Exp: 2025-08-20Common Shares (1,307,408 underlying)
  • Award

    Stock Option

    2022-03-02+840,000840,000 total
    Exercise: $2.44Exp: 2025-08-20Common Shares (840,000 underlying)
  • Award

    Stock Option

    2022-03-02+519,240519,240 total
    Exercise: $5.65Exp: 2032-03-01Common Shares (519,240 underlying)
Footnotes (3)
  • [F1]The stock option vests and is exercisable as to 25% of the underlying shares on April 1, 2020, and as to 2.083% of the underlying shares in 36 monthly installments commencing on May 1, 2020.
  • [F2]The stock option vests and is exercisable as to 25% of the underlying shares on August 21, 2021, and as to 2.083% of the underlying shares in 36 monthly installments commencing on September 1, 2021.
  • [F3]The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

Related Parties

1
  • filerCIK 0001860902

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 3:56 PM ET
Size
10.3 KB